

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | piRNA metabolic process (GO:0034587) | 8.67498881 |
| 2 | regulation of female gonad development (GO:2000194) | 7.17048055 |
| 3 | regulation of meiosis (GO:0040020) | 6.17344113 |
| 4 | protein K6-linked ubiquitination (GO:0085020) | 6.00852740 |
| 5 | regulation of exit from mitosis (GO:0007096) | 5.99614557 |
| 6 | female gamete generation (GO:0007292) | 5.93862859 |
| 7 | mitotic metaphase plate congression (GO:0007080) | 5.93711945 |
| 8 | histone H2A monoubiquitination (GO:0035518) | 5.90773031 |
| 9 | mitotic chromosome condensation (GO:0007076) | 5.81368281 |
| 10 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 5.74763759 |
| 11 | histone H2A ubiquitination (GO:0033522) | 5.45329106 |
| 12 | regulation of sister chromatid cohesion (GO:0007063) | 5.43777318 |
| 13 | oocyte maturation (GO:0001556) | 5.39870016 |
| 14 | regulation of meiotic cell cycle (GO:0051445) | 5.25359466 |
| 15 | regulation of histone H3-K27 methylation (GO:0061085) | 5.21565703 |
| 16 | activated T cell proliferation (GO:0050798) | 5.01790043 |
| 17 | negative regulation of meiosis (GO:0045835) | 5.00491861 |
| 18 | sphingosine metabolic process (GO:0006670) | 4.98364171 |
| 19 | DNA methylation involved in gamete generation (GO:0043046) | 4.97972305 |
| 20 | metaphase plate congression (GO:0051310) | 4.94982959 |
| 21 | base-excision repair, AP site formation (GO:0006285) | 4.91336059 |
| 22 | male meiosis (GO:0007140) | 4.90929581 |
| 23 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 4.83296004 |
| 24 | negative regulation of smooth muscle cell differentiation (GO:0051151) | 4.73760704 |
| 25 | establishment of chromosome localization (GO:0051303) | 4.62858035 |
| 26 | regulation of meiosis I (GO:0060631) | 4.60679656 |
| 27 | notochord development (GO:0030903) | 4.58955712 |
| 28 | meiotic cell cycle (GO:0051321) | 4.57683382 |
| 29 | negative regulation of meiotic cell cycle (GO:0051447) | 4.57589618 |
| 30 | DNA damage induced protein phosphorylation (GO:0006975) | 4.57528568 |
| 31 | attachment of spindle microtubules to kinetochore (GO:0008608) | 4.51561971 |
| 32 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.44534428 |
| 33 | diol metabolic process (GO:0034311) | 4.41836551 |
| 34 | female gonad development (GO:0008585) | 4.41625157 |
| 35 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 4.41158013 |
| 36 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.40510824 |
| 37 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.35223042 |
| 38 | sphingoid metabolic process (GO:0046519) | 4.33777783 |
| 39 | regulation of germinal center formation (GO:0002634) | 4.31248714 |
| 40 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 4.26314013 |
| 41 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.22622120 |
| 42 | positive regulation of meiotic cell cycle (GO:0051446) | 4.16953434 |
| 43 | gene silencing by RNA (GO:0031047) | 4.10777330 |
| 44 | regulation of acrosome reaction (GO:0060046) | 4.09895488 |
| 45 | ribosomal small subunit assembly (GO:0000028) | 4.09489014 |
| 46 | meiotic chromosome segregation (GO:0045132) | 4.08329682 |
| 47 | negative regulation of keratinocyte proliferation (GO:0010839) | 4.02674958 |
| 48 | citrulline biosynthetic process (GO:0019240) | 4.01374934 |
| 49 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.99845991 |
| 50 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.98313334 |
| 51 | microtubule severing (GO:0051013) | 3.97682202 |
| 52 | DNA damage response, signal transduction resulting in transcription (GO:0042772) | 3.97496677 |
| 53 | positive thymic T cell selection (GO:0045059) | 3.95817811 |
| 54 | regulation of keratinocyte proliferation (GO:0010837) | 3.95776838 |
| 55 | positive T cell selection (GO:0043368) | 3.95339687 |
| 56 | positive regulation of B cell differentiation (GO:0045579) | 3.87421000 |
| 57 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 3.76266941 |
| 58 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 3.76266941 |
| 59 | mitotic sister chromatid segregation (GO:0000070) | 3.75920075 |
| 60 | pyrimidine nucleotide catabolic process (GO:0006244) | 3.75569523 |
| 61 | DNA methylation (GO:0006306) | 3.68545906 |
| 62 | DNA alkylation (GO:0006305) | 3.68545906 |
| 63 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.64091107 |
| 64 | type B pancreatic cell development (GO:0003323) | 3.63806090 |
| 65 | mitotic sister chromatid cohesion (GO:0007064) | 3.61575615 |
| 66 | negative regulation of B cell apoptotic process (GO:0002903) | 3.58227525 |
| 67 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.57415419 |
| 68 | cell wall macromolecule metabolic process (GO:0044036) | 3.55939696 |
| 69 | maturation of 5.8S rRNA (GO:0000460) | 3.54779177 |
| 70 | protein localization to chromosome, centromeric region (GO:0071459) | 3.53489283 |
| 71 | myoblast migration (GO:0051451) | 3.52588327 |
| 72 | positive regulation of megakaryocyte differentiation (GO:0045654) | 3.52466534 |
| 73 | negative regulation of reproductive process (GO:2000242) | 3.52366627 |
| 74 | negative regulation of cell killing (GO:0031342) | 3.51352631 |
| 75 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.51352631 |
| 76 | negative regulation of hormone metabolic process (GO:0032351) | 3.50238693 |
| 77 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.50238693 |
| 78 | positive regulation of meiosis (GO:0045836) | 3.49486042 |
| 79 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.47374160 |
| 80 | purine deoxyribonucleotide catabolic process (GO:0009155) | 3.43218710 |
| 81 | oogenesis (GO:0048477) | 3.41623153 |
| 82 | regulation of keratinocyte differentiation (GO:0045616) | 3.40030418 |
| 83 | chaperone-mediated protein transport (GO:0072321) | 3.35806012 |
| 84 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.34756448 |
| 85 | sister chromatid cohesion (GO:0007062) | 3.34728378 |
| 86 | protein localization to kinetochore (GO:0034501) | 3.31424167 |
| 87 | regulation of transforming growth factor beta2 production (GO:0032909) | 3.30780645 |
| 88 | negative regulation of T-helper cell differentiation (GO:0045623) | 3.30449425 |
| 89 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 3.30449425 |
| 90 | oocyte development (GO:0048599) | 3.29604365 |
| 91 | regulation of spindle organization (GO:0090224) | 3.28676420 |
| 92 | ovulation cycle (GO:0042698) | 3.26770187 |
| 93 | protein localization to chromosome (GO:0034502) | 3.25825626 |
| 94 | ubiquinone biosynthetic process (GO:0006744) | 3.25633045 |
| 95 | multicellular organism reproduction (GO:0032504) | 3.25626923 |
| 96 | chromosome segregation (GO:0007059) | 3.25116857 |
| 97 | snRNA transcription (GO:0009301) | 3.23044921 |
| 98 | T cell selection (GO:0045058) | 3.19911039 |
| 99 | seminiferous tubule development (GO:0072520) | 3.19020726 |
| 100 | B cell receptor signaling pathway (GO:0050853) | 3.18910943 |
| 101 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.18792147 |
| 102 | definitive hemopoiesis (GO:0060216) | 3.18268969 |
| 103 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.17849294 |
| 104 | Peyers patch development (GO:0048541) | 3.17849294 |
| 105 | negative T cell selection (GO:0043383) | 3.17102830 |
| 106 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.13871267 |
| 107 | regulation of transcription from RNA polymerase I promoter (GO:0006356) | 3.13046169 |
| 108 | positive regulation of chromosome segregation (GO:0051984) | 3.12849343 |
| 109 | regulation of chromosome segregation (GO:0051983) | 3.11715642 |
| 110 | intestinal epithelial cell development (GO:0060576) | 3.11138847 |
| 111 | negative regulation of cell aging (GO:0090344) | 3.09134583 |
| 112 | positive regulation of chemokine secretion (GO:0090197) | 3.08132747 |
| 113 | synaptonemal complex assembly (GO:0007130) | 3.06794931 |
| 114 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05394386 |
| 115 | negative thymic T cell selection (GO:0045060) | 3.05214224 |
| 116 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.04827568 |
| 117 | glycerophospholipid catabolic process (GO:0046475) | 3.04548601 |
| 118 | mast cell activation involved in immune response (GO:0002279) | 3.04294995 |
| 119 | mast cell degranulation (GO:0043303) | 3.04294995 |
| 120 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.03588018 |
| 121 | regulation of DNA methylation (GO:0044030) | 3.02618252 |
| 122 | microtubule nucleation (GO:0007020) | 3.00512962 |
| 123 | regulation of establishment of cell polarity (GO:2000114) | 3.00226431 |
| 124 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.99153581 |
| 125 | resolution of meiotic recombination intermediates (GO:0000712) | 2.98700166 |
| 126 | meiotic nuclear division (GO:0007126) | 2.98357690 |
| 127 | response to interleukin-15 (GO:0070672) | 2.98047717 |
| 128 | cellular extravasation (GO:0045123) | 2.97262827 |
| 129 | meiotic cell cycle process (GO:1903046) | 2.97251332 |
| 130 | leukocyte cell-cell adhesion (GO:0007159) | 2.96595099 |
| 131 | spindle checkpoint (GO:0031577) | 2.95526955 |
| 132 | histone monoubiquitination (GO:0010390) | 2.93659352 |
| 133 | regulation of hypersensitivity (GO:0002883) | 2.92812042 |
| 134 | sister chromatid segregation (GO:0000819) | 2.92229087 |
| 135 | regulation of Cdc42 GTPase activity (GO:0043088) | 2.91572541 |
| 136 | neutrophil activation (GO:0042119) | 2.90758712 |
| 137 | kinetochore assembly (GO:0051382) | 2.88798248 |
| 138 | synaptic vesicle maturation (GO:0016188) | 2.88779093 |
| 139 | thymic T cell selection (GO:0045061) | 2.87919780 |
| 140 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.87546606 |
| 141 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.87546606 |
| 142 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.87546606 |
| 143 | purine deoxyribonucleotide metabolic process (GO:0009151) | 2.86823543 |
| 144 | germinal center formation (GO:0002467) | 2.86457395 |
| 145 | regulation of B cell differentiation (GO:0045577) | 2.85887443 |
| 146 | negative regulation of cell division (GO:0051782) | 2.84658158 |
| 147 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.83275120 |
| 148 | regulation of chemokine secretion (GO:0090196) | 2.82966865 |
| 149 | regulation of regulatory T cell differentiation (GO:0045589) | 2.82750789 |
| 150 | regulation of gamma-delta T cell activation (GO:0046643) | 2.81756981 |
| 151 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.80669961 |
| 152 | UV protection (GO:0009650) | 2.80457855 |
| 153 | response to misfolded protein (GO:0051788) | 2.78792070 |
| 154 | synaptic vesicle exocytosis (GO:0016079) | 2.77166614 |
| 155 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.75235342 |
| 156 | ncRNA 3-end processing (GO:0043628) | 2.73820088 |
| 157 | DNA integration (GO:0015074) | 2.73286163 |
| 158 | ubiquinone metabolic process (GO:0006743) | 2.71475743 |
| 159 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.69811144 |
| 160 | immunoglobulin mediated immune response (GO:0016064) | 2.68316345 |
| 161 | leukocyte aggregation (GO:0070486) | 2.65949728 |
| 162 | positive regulation of granulocyte differentiation (GO:0030854) | 2.65836761 |
| 163 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.65503589 |
| 164 | programmed necrotic cell death (GO:0097300) | 2.64810553 |
| 165 | neutrophil activation involved in immune response (GO:0002283) | 2.64430929 |
| 166 | granulocyte activation (GO:0036230) | 2.63744915 |
| 167 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.63218511 |
| 168 | necrotic cell death (GO:0070265) | 2.62853515 |
| 169 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.62172801 |
| 170 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.62172801 |
| 171 | regulation of activation of Janus kinase activity (GO:0010533) | 2.62032176 |
| 172 | mast cell activation (GO:0045576) | 2.61013851 |
| 173 | cellular response to exogenous dsRNA (GO:0071360) | 2.60999425 |
| 174 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.60368880 |
| 175 | purine deoxyribonucleoside triphosphate metabolic process (GO:0009215) | 2.59305259 |
| 176 | positive regulation of T cell differentiation in thymus (GO:0033089) | 2.58046089 |
| 177 | positive regulation of interleukin-4 production (GO:0032753) | 2.57000629 |
| 178 | heterotypic cell-cell adhesion (GO:0034113) | 2.55413981 |
| 179 | positive regulation of interleukin-17 production (GO:0032740) | 2.54147225 |
| 180 | cellular anion homeostasis (GO:0030002) | 2.52299181 |
| 181 | positive regulation of antigen processing and presentation (GO:0002579) | 2.50956884 |
| 182 | stress granule assembly (GO:0034063) | 2.50591440 |
| 183 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.50405197 |
| 184 | regulation of interleukin-4 production (GO:0032673) | 2.50167180 |
| 185 | actin nucleation (GO:0045010) | 2.49528699 |
| 186 | positive regulation of calcium-mediated signaling (GO:0050850) | 2.49385318 |
| 187 | T cell migration (GO:0072678) | 2.48987581 |
| 188 | leukocyte degranulation (GO:0043299) | 2.47864795 |
| 189 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.47482724 |
| 190 | quinone biosynthetic process (GO:1901663) | 2.46356405 |
| 191 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.45234114 |
| 192 | negative regulation of T cell apoptotic process (GO:0070233) | 2.44186992 |
| 193 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.42781622 |
| 194 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.42613719 |
| 195 | cellular response to interleukin-15 (GO:0071350) | 2.42337345 |
| 196 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.42272808 |
| 197 | regulation of synaptic vesicle transport (GO:1902803) | 2.41893827 |
| 198 | regulation of cytokine production involved in inflammatory response (GO:1900015) | 2.41195539 |
| 199 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.40214104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 5.88540722 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 4.04640062 |
| 3 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 3.82274716 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.56122691 |
| 5 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.45801894 |
| 6 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 3.42630705 |
| 7 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.38651225 |
| 8 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.31372427 |
| 9 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.18026592 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.15913629 |
| 11 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 3.11280238 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.88647303 |
| 13 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.73933095 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.67088392 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.62150839 |
| 16 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.61984082 |
| 17 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.61633645 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.44602510 |
| 19 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.39479328 |
| 20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.31940587 |
| 21 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 2.30660377 |
| 22 | MAF_26560356_Chip-Seq_TH2_Human | 2.28418087 |
| 23 | P68_20966046_ChIP-Seq_HELA_Human | 2.23771206 |
| 24 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.23426648 |
| 25 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.22809836 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.20716059 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 2.19847246 |
| 28 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.17372563 |
| 29 | MAF_26560356_Chip-Seq_TH1_Human | 2.13835947 |
| 30 | BCL6_27268052_Chip-Seq_Bcells_Human | 2.13709000 |
| 31 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.11573365 |
| 32 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.10520251 |
| 33 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.03535536 |
| 34 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.02778238 |
| 35 | BCOR_27268052_Chip-Seq_Bcells_Human | 2.01495499 |
| 36 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.00622939 |
| 37 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.00009252 |
| 38 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.98305677 |
| 39 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.97004704 |
| 40 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.92821248 |
| 41 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.90236432 |
| 42 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.90098037 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.88685302 |
| 44 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.87906067 |
| 45 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.87624356 |
| 46 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.85294883 |
| 47 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.81909689 |
| 48 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.81586615 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.75160686 |
| 50 | MYB_26560356_Chip-Seq_TH2_Human | 1.73576544 |
| 51 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.72119496 |
| 52 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.71650359 |
| 53 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.68524925 |
| 54 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.68447674 |
| 55 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.64723012 |
| 56 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.64489267 |
| 57 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.62859968 |
| 58 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.60213689 |
| 59 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.60170641 |
| 60 | RUNX1_26923725_Chip-Seq_HPCs_Mouse | 1.56266927 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.56159431 |
| 62 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.55552393 |
| 63 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.53681177 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.53198523 |
| 65 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.52845904 |
| 66 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.52704857 |
| 67 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.52344628 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.52235816 |
| 69 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.52154859 |
| 70 | * E2F1_20622854_ChIP-Seq_HELA_Human | 1.51966739 |
| 71 | * EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.51504699 |
| 72 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.51156041 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.50600698 |
| 74 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.50288255 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49459767 |
| 76 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.48427270 |
| 77 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.46684355 |
| 78 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.46575664 |
| 79 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.46140847 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45786172 |
| 81 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.45437556 |
| 82 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.43840259 |
| 83 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.42957544 |
| 84 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.42552949 |
| 85 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41704494 |
| 86 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41519829 |
| 87 | SPI1_23127762_ChIP-Seq_K562_Human | 1.41211825 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40770289 |
| 89 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.40448762 |
| 90 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40397058 |
| 91 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40288644 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.39126133 |
| 93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.39039424 |
| 94 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38184558 |
| 95 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.37611752 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 1.35944574 |
| 97 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.35051368 |
| 98 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.34834327 |
| 99 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.33546243 |
| 100 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.33025717 |
| 101 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.31331985 |
| 102 | MYB_26560356_Chip-Seq_TH1_Human | 1.30319011 |
| 103 | GATA3_21867929_ChIP-Seq_TH1_Mouse | 1.29710571 |
| 104 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.29170915 |
| 105 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 1.28789402 |
| 106 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.28769497 |
| 107 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.28452961 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.28443845 |
| 109 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28101766 |
| 110 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.27736896 |
| 111 | * MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.27733453 |
| 112 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.27688526 |
| 113 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.27258601 |
| 114 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27224740 |
| 115 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26735995 |
| 116 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.26466914 |
| 117 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25768279 |
| 118 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.25469551 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.25275145 |
| 120 | * NFYA_21822215_ChIP-Seq_K562_Human | 1.24674006 |
| 121 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.24585432 |
| 122 | NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.24492355 |
| 123 | FUS_26573619_Chip-Seq_HEK293_Human | 1.23878214 |
| 124 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.23877273 |
| 125 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.23495693 |
| 126 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.23263236 |
| 127 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.22326039 |
| 128 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.21292028 |
| 129 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.20686372 |
| 130 | * SA1_27219007_Chip-Seq_Bcells_Human | 1.20144313 |
| 131 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.19955851 |
| 132 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19761661 |
| 133 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.19554322 |
| 134 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.18606730 |
| 135 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18531209 |
| 136 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.18347108 |
| 137 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17430742 |
| 138 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.17340583 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17191585 |
| 140 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.16612363 |
| 141 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16259732 |
| 142 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.16259732 |
| 143 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.16238795 |
| 144 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.15977321 |
| 145 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.15852922 |
| 146 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.15533318 |
| 147 | * TBL1_22424771_ChIP-Seq_293T_Human | 1.15495175 |
| 148 | CJUN_26792858_Chip-Seq_BT549_Human | 1.15470667 |
| 149 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.14720551 |
| 150 | TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.14709882 |
| 151 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.14468804 |
| 152 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14081458 |
| 153 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.12641898 |
| 154 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.12529849 |
| 155 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.12425746 |
| 156 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.12416035 |
| 157 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11999767 |
| 158 | EWS_26573619_Chip-Seq_HEK293_Human | 1.11539093 |
| 159 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.11199319 |
| 160 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.11180208 |
| 161 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 1.10812885 |
| 162 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.10585586 |
| 163 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.08866006 |
| 164 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.08823916 |
| 165 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 1.08118059 |
| 166 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08049084 |
| 167 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.08010497 |
| 168 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.07740003 |
| 169 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.07433563 |
| 170 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.06956351 |
| 171 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.06946130 |
| 172 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.05661736 |
| 173 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.05651808 |
| 174 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03755493 |
| 175 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 1.03446085 |
| 176 | ERG_20517297_ChIP-Seq_VCAP_Human | 1.03315795 |
| 177 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.01120348 |
| 178 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.99676928 |
| 179 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99632500 |
| 180 | * RBPJ_21746931_ChIP-Seq_IB4_Human | 0.98674374 |
| 181 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.98297825 |
| 182 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.98020606 |
| 183 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.97355998 |
| 184 | GF1B_26923725_Chip-Seq_HPCs_Mouse | 0.96910609 |
| 185 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.96414468 |
| 186 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.96276469 |
| 187 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.96144141 |
| 188 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.95525773 |
| 189 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.94144109 |
| 190 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.94020066 |
| 191 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.93823114 |
| 192 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.92419621 |
| 193 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91259053 |
| 194 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.90605225 |
| 195 | KAP1_27257070_Chip-Seq_ESCs_Mouse | 0.89400461 |
| 196 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.89351623 |
| 197 | VDR_22108803_ChIP-Seq_LS180_Human | 0.87570218 |
| 198 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.86043821 |
| 199 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.86009692 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003718_maternal_effect | 6.22116175 |
| 2 | MP0003646_muscle_fatigue | 4.81104617 |
| 3 | MP0005451_abnormal_body_composition | 4.77100566 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.64378177 |
| 5 | MP0001835_abnormal_antigen_presentation | 3.19485010 |
| 6 | MP0003787_abnormal_imprinting | 3.12557943 |
| 7 | MP0008877_abnormal_DNA_methylation | 3.05453013 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.87393912 |
| 9 | MP0000579_abnormal_nail_morphology | 2.84500936 |
| 10 | MP0001986_abnormal_taste_sensitivity | 2.82559112 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.73301737 |
| 12 | MP0005395_other_phenotype | 2.65014587 |
| 13 | MP0002102_abnormal_ear_morphology | 2.64977783 |
| 14 | MP0003699_abnormal_female_reproductive | 2.61937216 |
| 15 | MP0002653_abnormal_ependyma_morphology | 2.59783632 |
| 16 | MP0004957_abnormal_blastocyst_morpholog | 2.49535883 |
| 17 | MP0005671_abnormal_response_to | 2.46723405 |
| 18 | MP0006292_abnormal_olfactory_placode | 2.45021663 |
| 19 | MP0003111_abnormal_nucleus_morphology | 2.39137623 |
| 20 | MP0001800_abnormal_humoral_immune | 2.38094517 |
| 21 | MP0001119_abnormal_female_reproductive | 2.37869966 |
| 22 | MP0005000_abnormal_immune_tolerance | 2.36782532 |
| 23 | MP0003123_paternal_imprinting | 2.36555437 |
| 24 | MP0003077_abnormal_cell_cycle | 2.34391681 |
| 25 | MP0010094_abnormal_chromosome_stability | 2.33925872 |
| 26 | MP0003315_abnormal_perineum_morphology | 2.30804334 |
| 27 | MP0003724_increased_susceptibility_to | 2.27475334 |
| 28 | MP0003436_decreased_susceptibility_to | 2.20730490 |
| 29 | MP0005025_abnormal_response_to | 2.18221772 |
| 30 | MP0002796_impaired_skin_barrier | 2.14377169 |
| 31 | MP0005423_abnormal_somatic_nervous | 2.13227772 |
| 32 | MP0009379_abnormal_foot_pigmentation | 2.09983573 |
| 33 | MP0002723_abnormal_immune_serum | 2.08091597 |
| 34 | MP0003941_abnormal_skin_development | 2.06906369 |
| 35 | MP0002148_abnormal_hypersensitivity_rea | 2.04373420 |
| 36 | MP0001188_hyperpigmentation | 2.03614059 |
| 37 | MP0002420_abnormal_adaptive_immunity | 2.00453731 |
| 38 | MP0003937_abnormal_limbs/digits/tail_de | 1.98978037 |
| 39 | MP0001929_abnormal_gametogenesis | 1.95144797 |
| 40 | MP0001819_abnormal_immune_cell | 1.94711315 |
| 41 | MP0002419_abnormal_innate_immunity | 1.92135365 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.90237669 |
| 43 | MP0009278_abnormal_bone_marrow | 1.89258923 |
| 44 | MP0000685_abnormal_immune_system | 1.89162324 |
| 45 | MP0002452_abnormal_antigen_presenting | 1.88802089 |
| 46 | MP0002398_abnormal_bone_marrow | 1.88654636 |
| 47 | MP0002249_abnormal_larynx_morphology | 1.87729011 |
| 48 | MP0000653_abnormal_sex_gland | 1.84700787 |
| 49 | MP0001346_abnormal_lacrimal_gland | 1.79272512 |
| 50 | MP0004185_abnormal_adipocyte_glucose | 1.79238086 |
| 51 | MP0002210_abnormal_sex_determination | 1.78532572 |
| 52 | MP0003121_genomic_imprinting | 1.74074853 |
| 53 | MP0005464_abnormal_platelet_physiology | 1.71603552 |
| 54 | MP0005646_abnormal_pituitary_gland | 1.70289308 |
| 55 | MP0005408_hypopigmentation | 1.69592997 |
| 56 | MP0000716_abnormal_immune_system | 1.68595960 |
| 57 | MP0006082_CNS_inflammation | 1.67950814 |
| 58 | MP0005387_immune_system_phenotype | 1.65323345 |
| 59 | MP0001790_abnormal_immune_system | 1.65323345 |
| 60 | MP0001968_abnormal_touch/_nociception | 1.61459133 |
| 61 | MP0005187_abnormal_penis_morphology | 1.61382753 |
| 62 | MP0001851_eye_inflammation | 1.61328222 |
| 63 | MP0003866_abnormal_defecation | 1.60511424 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.59809897 |
| 65 | MP0004381_abnormal_hair_follicle | 1.58765865 |
| 66 | MP0003635_abnormal_synaptic_transmissio | 1.56891635 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.52943337 |
| 68 | MP0000689_abnormal_spleen_morphology | 1.52314553 |
| 69 | MP0002722_abnormal_immune_system | 1.50892060 |
| 70 | MP0000681_abnormal_thyroid_gland | 1.50274690 |
| 71 | MP0002877_abnormal_melanocyte_morpholog | 1.49346534 |
| 72 | MP0002060_abnormal_skin_morphology | 1.48481414 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.47839223 |
| 74 | MP0009785_altered_susceptibility_to | 1.46680500 |
| 75 | MP0000427_abnormal_hair_cycle | 1.46458726 |
| 76 | MP0000383_abnormal_hair_follicle | 1.44834656 |
| 77 | MP0004947_skin_inflammation | 1.43350485 |
| 78 | MP0000566_synostosis | 1.41738188 |
| 79 | MP0008932_abnormal_embryonic_tissue | 1.39949439 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 1.35320595 |
| 81 | MP0002933_joint_inflammation | 1.35218143 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.34932516 |
| 83 | MP0003136_yellow_coat_color | 1.34557179 |
| 84 | MP0002429_abnormal_blood_cell | 1.32326371 |
| 85 | MP0003690_abnormal_glial_cell | 1.31510902 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 1.31461172 |
| 87 | MP0005257_abnormal_intraocular_pressure | 1.31198777 |
| 88 | MP0005174_abnormal_tail_pigmentation | 1.30997930 |
| 89 | MP0003880_abnormal_central_pattern | 1.28004010 |
| 90 | MP0002064_seizures | 1.27699560 |
| 91 | MP0008569_lethality_at_weaning | 1.26916956 |
| 92 | MP0004043_abnormal_pH_regulation | 1.26882257 |
| 93 | MP0002405_respiratory_system_inflammati | 1.26248973 |
| 94 | MP0004142_abnormal_muscle_tone | 1.25749040 |
| 95 | MP0003938_abnormal_ear_development | 1.25560790 |
| 96 | MP0001216_abnormal_epidermal_layer | 1.24642904 |
| 97 | MP0008007_abnormal_cellular_replicative | 1.24598303 |
| 98 | MP0002733_abnormal_thermal_nociception | 1.23812815 |
| 99 | MP0005397_hematopoietic_system_phenotyp | 1.23799643 |
| 100 | MP0001545_abnormal_hematopoietic_system | 1.23799643 |
| 101 | MP0010678_abnormal_skin_adnexa | 1.23301351 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 1.22880238 |
| 103 | MP0005535_abnormal_body_temperature | 1.22316851 |
| 104 | MP0001502_abnormal_circadian_rhythm | 1.19512855 |
| 105 | MP0001145_abnormal_male_reproductive | 1.18859150 |
| 106 | MP0005501_abnormal_skin_physiology | 1.18685933 |
| 107 | MP0002161_abnormal_fertility/fecundity | 1.17884803 |
| 108 | MP0010155_abnormal_intestine_physiology | 1.17844256 |
| 109 | MP0002085_abnormal_embryonic_tissue | 1.16296849 |
| 110 | MP0002063_abnormal_learning/memory/cond | 1.15319722 |
| 111 | MP0005058_abnormal_lysosome_morphology | 1.14887541 |
| 112 | MP0003755_abnormal_palate_morphology | 1.14818947 |
| 113 | MP0000350_abnormal_cell_proliferation | 1.13649680 |
| 114 | MP0002822_catalepsy | 1.13371504 |
| 115 | MP0001486_abnormal_startle_reflex | 1.13345475 |
| 116 | MP0005310_abnormal_salivary_gland | 1.13089563 |
| 117 | MP0006035_abnormal_mitochondrial_morpho | 1.11933273 |
| 118 | MP0006036_abnormal_mitochondrial_physio | 1.11252685 |
| 119 | MP0001970_abnormal_pain_threshold | 1.09499294 |
| 120 | MP0002572_abnormal_emotion/affect_behav | 1.07560088 |
| 121 | MP0003950_abnormal_plasma_membrane | 1.06787870 |
| 122 | MP0001730_embryonic_growth_arrest | 1.06406667 |
| 123 | MP0006276_abnormal_autonomic_nervous | 1.06087198 |
| 124 | MP0000613_abnormal_salivary_gland | 1.05860723 |
| 125 | MP0000647_abnormal_sebaceous_gland | 1.05432406 |
| 126 | MP0001845_abnormal_inflammatory_respons | 1.03812981 |
| 127 | MP0002396_abnormal_hematopoietic_system | 1.03641486 |
| 128 | MP0000462_abnormal_digestive_system | 1.03573236 |
| 129 | MP0002163_abnormal_gland_morphology | 1.02805726 |
| 130 | MP0009745_abnormal_behavioral_response | 1.02539826 |
| 131 | MP0001529_abnormal_vocalization | 1.01401076 |
| 132 | MP0000015_abnormal_ear_pigmentation | 1.01299653 |
| 133 | MP0004264_abnormal_extraembryonic_tissu | 1.00432919 |
| 134 | MP0005645_abnormal_hypothalamus_physiol | 0.99871029 |
| 135 | MP0003879_abnormal_hair_cell | 0.98405891 |
| 136 | MP0002084_abnormal_developmental_patter | 0.98382123 |
| 137 | MP0002098_abnormal_vibrissa_morphology | 0.98381942 |
| 138 | MP0001853_heart_inflammation | 0.95010870 |
| 139 | MP0010030_abnormal_orbit_morphology | 0.93602134 |
| 140 | MP0001849_ear_inflammation | 0.91083301 |
| 141 | MP0010771_integument_phenotype | 0.89867610 |
| 142 | MP0002272_abnormal_nervous_system | 0.89723904 |
| 143 | MP0008874_decreased_physiological_sensi | 0.89117041 |
| 144 | MP0008469_abnormal_protein_level | 0.87866152 |
| 145 | MP0008260_abnormal_autophagy | 0.87786614 |
| 146 | MP0002067_abnormal_sensory_capabilities | 0.86709347 |
| 147 | MP0009384_cardiac_valve_regurgitation | 0.86137208 |
| 148 | MP0002166_altered_tumor_susceptibility | 0.85829972 |
| 149 | MP0001672_abnormal_embryogenesis/_devel | 0.84800842 |
| 150 | MP0005380_embryogenesis_phenotype | 0.84800842 |
| 151 | MP0002332_abnormal_exercise_endurance | 0.84393787 |
| 152 | MP0001697_abnormal_embryo_size | 0.82939457 |
| 153 | MP0009046_muscle_twitch | 0.82510900 |
| 154 | MP0000490_abnormal_crypts_of | 0.81616409 |
| 155 | MP0002009_preneoplasia | 0.80963312 |
| 156 | MP0001765_abnormal_ion_homeostasis | 0.80689692 |
| 157 | MP0000920_abnormal_myelination | 0.77729176 |
| 158 | MP0009250_abnormal_appendicular_skeleto | 0.77444070 |
| 159 | MP0000377_abnormal_hair_follicle | 0.77275204 |
| 160 | MP0001764_abnormal_homeostasis | 0.76358455 |
| 161 | MP0002006_tumorigenesis | 0.76072264 |
| 162 | MP0008873_increased_physiological_sensi | 0.75602070 |
| 163 | MP0005647_abnormal_sex_gland | 0.74673840 |
| 164 | MP0002177_abnormal_outer_ear | 0.74401495 |
| 165 | MP0008872_abnormal_physiological_respon | 0.74314806 |
| 166 | MP0002735_abnormal_chemical_nociception | 0.74283013 |
| 167 | MP0002019_abnormal_tumor_incidence | 0.73984050 |
| 168 | MP0000639_abnormal_adrenal_gland | 0.73945584 |
| 169 | MP0005166_decreased_susceptibility_to | 0.73876179 |
| 170 | MP0003183_abnormal_peptide_metabolism | 0.73348268 |
| 171 | MP0008961_abnormal_basal_metabolism | 0.72061843 |
| 172 | MP0004130_abnormal_muscle_cell | 0.71094786 |
| 173 | MP0001915_intracranial_hemorrhage | 0.70470539 |
| 174 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70176569 |
| 175 | MP0003329_amyloid_beta_deposits | 0.69800124 |
| 176 | MP0008995_early_reproductive_senescence | 0.68441520 |
| 177 | MP0000432_abnormal_head_morphology | 0.68354789 |
| 178 | MP0002233_abnormal_nose_morphology | 0.66858664 |
| 179 | MP0004782_abnormal_surfactant_physiolog | 0.65227618 |
| 180 | MP0005248_abnormal_Harderian_gland | 0.64956831 |
| 181 | MP0002116_abnormal_craniofacial_bone | 0.63270336 |
| 182 | MP0001340_abnormal_eyelid_morphology | 0.63208771 |
| 183 | MP0000627_abnormal_mammary_gland | 0.62637013 |
| 184 | MP0003786_premature_aging | 0.62282525 |
| 185 | MP0001905_abnormal_dopamine_level | 0.61648389 |
| 186 | MP0010386_abnormal_urinary_bladder | 0.61331470 |
| 187 | MP0005621_abnormal_cell_physiology | 0.60699957 |
| 188 | MP0002282_abnormal_trachea_morphology | 0.60609398 |
| 189 | MP0003698_abnormal_male_reproductive | 0.60039152 |
| 190 | MP0003935_abnormal_craniofacial_develop | 0.60006358 |
| 191 | MP0010368_abnormal_lymphatic_system | 0.59877670 |
| 192 | MP0001919_abnormal_reproductive_system | 0.59440009 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Male infertility (HP:0003251) | 7.09447171 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.99145956 |
| 3 | Lip pit (HP:0100267) | 4.92586116 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.60151956 |
| 5 | Papillary thyroid carcinoma (HP:0002895) | 4.52626786 |
| 6 | Cortical dysplasia (HP:0002539) | 4.42228755 |
| 7 | Premature ovarian failure (HP:0008209) | 4.40391843 |
| 8 | Chromsome breakage (HP:0040012) | 4.33255178 |
| 9 | Recurrent abscess formation (HP:0002722) | 4.16602916 |
| 10 | Breast hypoplasia (HP:0003187) | 4.09440108 |
| 11 | Birth length less than 3rd percentile (HP:0003561) | 4.03786002 |
| 12 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.97490763 |
| 13 | Shawl scrotum (HP:0000049) | 3.89911001 |
| 14 | Facial hemangioma (HP:0000329) | 3.88365654 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 3.81652563 |
| 16 | Infertility (HP:0000789) | 3.75057508 |
| 17 | Flat capital femoral epiphysis (HP:0003370) | 3.68679642 |
| 18 | Leukocytosis (HP:0001974) | 3.68203257 |
| 19 | Patellar aplasia (HP:0006443) | 3.67448423 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.64892695 |
| 21 | Adrenal hypoplasia (HP:0000835) | 3.58928476 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.57033258 |
| 23 | Granulocytopenia (HP:0001913) | 3.54865147 |
| 24 | Aplasia/Hypoplasia of the patella (HP:0006498) | 3.54528716 |
| 25 | Autoimmune hemolytic anemia (HP:0001890) | 3.43091825 |
| 26 | Agammaglobulinemia (HP:0004432) | 3.42291250 |
| 27 | Gingivitis (HP:0000230) | 3.39926675 |
| 28 | Periodontitis (HP:0000704) | 3.38985124 |
| 29 | Aplasia/Hypoplasia of the breasts (HP:0010311) | 3.38496723 |
| 30 | Breast aplasia (HP:0100783) | 3.36195790 |
| 31 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.34038372 |
| 32 | Severe combined immunodeficiency (HP:0004430) | 3.32474435 |
| 33 | Stomatitis (HP:0010280) | 3.27545957 |
| 34 | Poikiloderma (HP:0001029) | 3.26953566 |
| 35 | Eosinophilia (HP:0001880) | 3.25485735 |
| 36 | Thrombocytosis (HP:0001894) | 3.24936196 |
| 37 | Attenuation of retinal blood vessels (HP:0007843) | 3.17355103 |
| 38 | Increased IgE level (HP:0003212) | 3.14756816 |
| 39 | Abnormality of the labia minora (HP:0012880) | 3.10189841 |
| 40 | Milia (HP:0001056) | 3.04331902 |
| 41 | Abnormality of eosinophils (HP:0001879) | 3.01857356 |
| 42 | Secondary amenorrhea (HP:0000869) | 3.00892622 |
| 43 | Myositis (HP:0100614) | 2.94787626 |
| 44 | Meningitis (HP:0001287) | 2.90473291 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.89920059 |
| 46 | Diplopia (HP:0000651) | 2.89920059 |
| 47 | Chronic otitis media (HP:0000389) | 2.87650802 |
| 48 | Acute myeloid leukemia (HP:0004808) | 2.86797455 |
| 49 | Capillary hemangiomas (HP:0005306) | 2.85840482 |
| 50 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.82829163 |
| 51 | Prostate neoplasm (HP:0100787) | 2.82037474 |
| 52 | Abnormality of the fovea (HP:0000493) | 2.82001540 |
| 53 | Hemiplegia (HP:0002301) | 2.77495934 |
| 54 | Papilledema (HP:0001085) | 2.76224036 |
| 55 | Abnormality of the fingertips (HP:0001211) | 2.74988554 |
| 56 | Oligodactyly (hands) (HP:0001180) | 2.72778308 |
| 57 | Cellulitis (HP:0100658) | 2.72097337 |
| 58 | Recurrent fungal infections (HP:0002841) | 2.71932345 |
| 59 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.71456159 |
| 60 | Hypoplasia of the fovea (HP:0007750) | 2.71456159 |
| 61 | Hypergammaglobulinemia (HP:0010702) | 2.70036418 |
| 62 | Obstructive lung disease (HP:0006536) | 2.69770681 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.69770681 |
| 64 | Pustule (HP:0200039) | 2.66558161 |
| 65 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.66513716 |
| 66 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.64016742 |
| 67 | Myokymia (HP:0002411) | 2.63915745 |
| 68 | Abnormality of lateral ventricle (HP:0030047) | 2.63231206 |
| 69 | Ankle clonus (HP:0011448) | 2.60915101 |
| 70 | Cerebral palsy (HP:0100021) | 2.55923779 |
| 71 | Primary amenorrhea (HP:0000786) | 2.55417002 |
| 72 | Fragile nails (HP:0001808) | 2.53279768 |
| 73 | Hyperglycemia (HP:0003074) | 2.52198060 |
| 74 | Atelectasis (HP:0100750) | 2.49716968 |
| 75 | Hypergonadotropic hypogonadism (HP:0000815) | 2.49597300 |
| 76 | Combined immunodeficiency (HP:0005387) | 2.48462526 |
| 77 | Abnormality of the phalanges of the hallux (HP:0010057) | 2.46123201 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 2.43690333 |
| 79 | Increased cerebral lipofuscin (HP:0011813) | 2.42138549 |
| 80 | Malnutrition (HP:0004395) | 2.41701054 |
| 81 | Oligodactyly (HP:0012165) | 2.40740800 |
| 82 | Parakeratosis (HP:0001036) | 2.40527932 |
| 83 | Abnormality of the preputium (HP:0100587) | 2.37038218 |
| 84 | Chronic bronchitis (HP:0004469) | 2.35114824 |
| 85 | Annular pancreas (HP:0001734) | 2.34426878 |
| 86 | B lymphocytopenia (HP:0010976) | 2.34123638 |
| 87 | Eczematoid dermatitis (HP:0000976) | 2.33855986 |
| 88 | Encephalitis (HP:0002383) | 2.32701504 |
| 89 | Abnormality of B cell number (HP:0010975) | 2.32559788 |
| 90 | Prolonged bleeding time (HP:0003010) | 2.27744708 |
| 91 | Thyroid carcinoma (HP:0002890) | 2.26652762 |
| 92 | Dyschromatopsia (HP:0007641) | 2.24944528 |
| 93 | Anterior segment dysgenesis (HP:0007700) | 2.23175730 |
| 94 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 2.22197613 |
| 95 | Short thumb (HP:0009778) | 2.21469417 |
| 96 | Hypertensive crisis (HP:0100735) | 2.21454364 |
| 97 | Increased IgM level (HP:0003496) | 2.19851886 |
| 98 | Atrioventricular block (HP:0001678) | 2.17014587 |
| 99 | Chest pain (HP:0100749) | 2.16846861 |
| 100 | Pulmonary fibrosis (HP:0002206) | 2.15657695 |
| 101 | Microvesicular hepatic steatosis (HP:0001414) | 2.15324841 |
| 102 | Hypotrichosis (HP:0001006) | 2.15029479 |
| 103 | Congenital stationary night blindness (HP:0007642) | 2.14997517 |
| 104 | Chin dimple (HP:0010751) | 2.14368796 |
| 105 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 2.12862995 |
| 106 | Abnormality of chromosome stability (HP:0003220) | 2.12215189 |
| 107 | Spinal canal stenosis (HP:0003416) | 2.11887718 |
| 108 | Absent radius (HP:0003974) | 2.11743293 |
| 109 | Rhabdomyolysis (HP:0003201) | 2.11520311 |
| 110 | Tetraplegia (HP:0002445) | 2.11417064 |
| 111 | Rib fusion (HP:0000902) | 2.10916966 |
| 112 | Midline defect of the nose (HP:0004122) | 2.10503874 |
| 113 | Fibular aplasia (HP:0002990) | 2.10112911 |
| 114 | Status epilepticus (HP:0002133) | 2.08505442 |
| 115 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.08223119 |
| 116 | Arterial tortuosity (HP:0005116) | 2.07874589 |
| 117 | Microglossia (HP:0000171) | 2.07397348 |
| 118 | Sandal gap (HP:0001852) | 2.07186812 |
| 119 | Aplasia/Hypoplasia of the sternum (HP:0006714) | 2.07061201 |
| 120 | Meckel diverticulum (HP:0002245) | 2.06017775 |
| 121 | 3-Methylglutaconic aciduria (HP:0003535) | 2.05879030 |
| 122 | Abnormality of T cell number (HP:0011839) | 2.05738790 |
| 123 | Absent forearm bone (HP:0003953) | 2.05060999 |
| 124 | Aplasia involving forearm bones (HP:0009822) | 2.05060999 |
| 125 | Anosmia (HP:0000458) | 2.03082115 |
| 126 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.02648927 |
| 127 | Abnormality of chromosome segregation (HP:0002916) | 2.02090575 |
| 128 | Increased intramyocellular lipid droplets (HP:0012240) | 2.01921234 |
| 129 | Increased muscle lipid content (HP:0009058) | 2.01795866 |
| 130 | Abnormality of T cells (HP:0002843) | 2.01547920 |
| 131 | Oligodontia (HP:0000677) | 2.01446171 |
| 132 | Recurrent viral infections (HP:0004429) | 2.01348275 |
| 133 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99803965 |
| 134 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99803965 |
| 135 | Focal motor seizures (HP:0011153) | 1.99773908 |
| 136 | Sparse scalp hair (HP:0002209) | 1.99044734 |
| 137 | Sparse lateral eyebrow (HP:0005338) | 1.98913755 |
| 138 | Blepharitis (HP:0000498) | 1.97672828 |
| 139 | Onycholysis (HP:0001806) | 1.97333044 |
| 140 | Poor eye contact (HP:0000817) | 1.96881952 |
| 141 | Aplasia involving bones of the extremities (HP:0009825) | 1.95767204 |
| 142 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.95767204 |
| 143 | Aplasia of the phalanges of the hand (HP:0009802) | 1.95767204 |
| 144 | Brushfield spots (HP:0001088) | 1.95604725 |
| 145 | Cerebral hypomyelination (HP:0006808) | 1.95444513 |
| 146 | Ragged-red muscle fibers (HP:0003200) | 1.94811239 |
| 147 | Epileptic encephalopathy (HP:0200134) | 1.94569559 |
| 148 | Fetal akinesia sequence (HP:0001989) | 1.93802710 |
| 149 | Posterior embryotoxon (HP:0000627) | 1.93725803 |
| 150 | Sepsis (HP:0100806) | 1.92399530 |
| 151 | Vasculitis (HP:0002633) | 1.91520622 |
| 152 | Urticaria (HP:0001025) | 1.91289543 |
| 153 | Supernumerary spleens (HP:0009799) | 1.89886178 |
| 154 | Hypochromic anemia (HP:0001931) | 1.89584820 |
| 155 | Inflammation of the large intestine (HP:0002037) | 1.88091996 |
| 156 | Abnormality of the labia (HP:0000058) | 1.87293114 |
| 157 | Duodenal stenosis (HP:0100867) | 1.86933177 |
| 158 | Small intestinal stenosis (HP:0012848) | 1.86933177 |
| 159 | Mesangial abnormality (HP:0001966) | 1.86031648 |
| 160 | Recurrent bacterial skin infections (HP:0005406) | 1.84923482 |
| 161 | Abnormality of the ileum (HP:0001549) | 1.84911284 |
| 162 | Clubbing of toes (HP:0100760) | 1.84504478 |
| 163 | Global brain atrophy (HP:0002283) | 1.84190318 |
| 164 | Deep palmar crease (HP:0006191) | 1.83960506 |
| 165 | Abnormality of the line of Schwalbe (HP:0008048) | 1.83777676 |
| 166 | Myelodysplasia (HP:0002863) | 1.82737828 |
| 167 | Thoracic kyphosis (HP:0002942) | 1.82265902 |
| 168 | Abnormality of DNA repair (HP:0003254) | 1.82249151 |
| 169 | Testicular atrophy (HP:0000029) | 1.82065949 |
| 170 | Gastrointestinal inflammation (HP:0004386) | 1.81472972 |
| 171 | Increased serum ferritin (HP:0003281) | 1.80262293 |
| 172 | Gastrointestinal infarctions (HP:0005244) | 1.78880929 |
| 173 | Erythema (HP:0010783) | 1.78456487 |
| 174 | Abnormality of the labia majora (HP:0012881) | 1.77792562 |
| 175 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.77067278 |
| 176 | Dicarboxylic aciduria (HP:0003215) | 1.77067278 |
| 177 | Ectropion (HP:0000656) | 1.76832698 |
| 178 | J-shaped sella turcica (HP:0002680) | 1.76116944 |
| 179 | Reduced antithrombin III activity (HP:0001976) | 1.75686887 |
| 180 | Abnormal number of erythroid precursors (HP:0012131) | 1.75431000 |
| 181 | Overlapping toe (HP:0001845) | 1.75330115 |
| 182 | Visual hallucinations (HP:0002367) | 1.74470286 |
| 183 | Ectopic kidney (HP:0000086) | 1.73882327 |
| 184 | Abnormality of T cell physiology (HP:0011840) | 1.73528353 |
| 185 | Absent eyebrow (HP:0002223) | 1.73074632 |
| 186 | Curly hair (HP:0002212) | 1.72500887 |
| 187 | Obstructive sleep apnea (HP:0002870) | 1.72407372 |
| 188 | Epistaxis (HP:0000421) | 1.71968961 |
| 189 | Vascular tortuosity (HP:0004948) | 1.71404778 |
| 190 | Hypoplastic pelvis (HP:0008839) | 1.69701566 |
| 191 | Microtia (HP:0008551) | 1.68818765 |
| 192 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.67720780 |
| 193 | Nail dystrophy (HP:0008404) | 1.67500050 |
| 194 | Woolly hair (HP:0002224) | 1.67139390 |
| 195 | Cystic hygroma (HP:0000476) | 1.67076074 |
| 196 | Popliteal pterygium (HP:0009756) | 1.66885738 |
| 197 | Impulsivity (HP:0100710) | 1.66795414 |
| 198 | Bifid tongue (HP:0010297) | 1.63458307 |
| 199 | Skin pits (HP:0100276) | 1.63254611 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LATS1 | 5.59434857 |
| 2 | LATS2 | 5.08139198 |
| 3 | MAP3K6 | 4.41820118 |
| 4 | MAP4K1 | 4.12247465 |
| 5 | STK38L | 3.95518087 |
| 6 | ERBB4 | 3.61172206 |
| 7 | TAOK3 | 3.07119674 |
| 8 | FES | 3.05657149 |
| 9 | BCKDK | 2.91977201 |
| 10 | KSR2 | 2.73469312 |
| 11 | TXK | 2.58771282 |
| 12 | TESK2 | 2.56942767 |
| 13 | PLK4 | 2.52900995 |
| 14 | PRKCH | 2.38667985 |
| 15 | MAPKAPK3 | 2.34698860 |
| 16 | DAPK2 | 2.29557920 |
| 17 | EEF2K | 2.28947661 |
| 18 | MAP3K11 | 2.24097937 |
| 19 | TAOK1 | 2.23922405 |
| 20 | STK3 | 2.23891388 |
| 21 | MOS | 2.19884397 |
| 22 | PRKD3 | 2.14573261 |
| 23 | TTK | 2.11557581 |
| 24 | MAP3K13 | 2.10402459 |
| 25 | SIK2 | 2.08539687 |
| 26 | GRK6 | 2.05818191 |
| 27 | TNK2 | 2.01150060 |
| 28 | MAP2K3 | 2.00176387 |
| 29 | BRAF | 1.97033904 |
| 30 | SYK | 1.92179739 |
| 31 | CDK8 | 1.90007723 |
| 32 | CDC7 | 1.87912167 |
| 33 | RAF1 | 1.85458288 |
| 34 | BMPR2 | 1.81210344 |
| 35 | CAMKK1 | 1.81066157 |
| 36 | DAPK1 | 1.79190467 |
| 37 | MAP3K9 | 1.79039108 |
| 38 | ICK | 1.72256785 |
| 39 | TBK1 | 1.71302472 |
| 40 | RIPK4 | 1.70652721 |
| 41 | MUSK | 1.68733599 |
| 42 | CHEK2 | 1.67269506 |
| 43 | DYRK2 | 1.66776533 |
| 44 | ITK | 1.53683230 |
| 45 | CSF1R | 1.50412606 |
| 46 | MELK | 1.45728978 |
| 47 | ZAP70 | 1.44291733 |
| 48 | KDR | 1.44095767 |
| 49 | KIT | 1.37645372 |
| 50 | ARAF | 1.36989075 |
| 51 | CAMKK2 | 1.35818568 |
| 52 | MAPKAPK5 | 1.31769734 |
| 53 | CDK9 | 1.29922419 |
| 54 | LCK | 1.28290756 |
| 55 | BTK | 1.28010844 |
| 56 | NME2 | 1.27519862 |
| 57 | DMPK | 1.27268494 |
| 58 | JAK3 | 1.24966534 |
| 59 | MAP2K6 | 1.24648214 |
| 60 | STK24 | 1.18806846 |
| 61 | MAPK12 | 1.18123651 |
| 62 | PIM2 | 1.16500107 |
| 63 | NEK2 | 1.15850713 |
| 64 | ABL2 | 1.15812365 |
| 65 | PRPF4B | 1.15279663 |
| 66 | STK38 | 1.10296359 |
| 67 | PRKD2 | 1.08866752 |
| 68 | MAPK13 | 1.05944393 |
| 69 | CSK | 1.05686478 |
| 70 | MAP3K4 | 1.05371292 |
| 71 | PLK1 | 1.03444401 |
| 72 | TYRO3 | 0.96973242 |
| 73 | STK10 | 0.96919753 |
| 74 | PRKCQ | 0.95652057 |
| 75 | CDK3 | 0.93101158 |
| 76 | MARK1 | 0.92689101 |
| 77 | BLK | 0.90140254 |
| 78 | PDK1 | 0.89087096 |
| 79 | AURKB | 0.85342723 |
| 80 | ADRBK1 | 0.85311483 |
| 81 | RPS6KB2 | 0.83657753 |
| 82 | TEC | 0.81810911 |
| 83 | GRK7 | 0.81518132 |
| 84 | PAK6 | 0.80254465 |
| 85 | MINK1 | 0.79089312 |
| 86 | IKBKB | 0.79055409 |
| 87 | KSR1 | 0.76940460 |
| 88 | IKBKE | 0.76606526 |
| 89 | MAP2K4 | 0.76567613 |
| 90 | HCK | 0.75168212 |
| 91 | CSNK1G1 | 0.75141033 |
| 92 | MAP3K5 | 0.74941792 |
| 93 | MAP3K8 | 0.71858185 |
| 94 | MAP3K1 | 0.70674730 |
| 95 | RPS6KA2 | 0.70671962 |
| 96 | MAP2K7 | 0.68512350 |
| 97 | NTRK3 | 0.68126436 |
| 98 | RET | 0.68052543 |
| 99 | LYN | 0.67833336 |
| 100 | AKT3 | 0.67212073 |
| 101 | MAP3K2 | 0.65297871 |
| 102 | UHMK1 | 0.65263387 |
| 103 | RPS6KC1 | 0.65099927 |
| 104 | RPS6KL1 | 0.65099927 |
| 105 | MAPK15 | 0.64411986 |
| 106 | AURKA | 0.63355695 |
| 107 | PBK | 0.63202404 |
| 108 | ACVR1B | 0.61714504 |
| 109 | NTRK2 | 0.61175112 |
| 110 | BUB1 | 0.61145816 |
| 111 | VRK2 | 0.60467292 |
| 112 | PRKAA2 | 0.60271810 |
| 113 | RPS6KA6 | 0.58805180 |
| 114 | NLK | 0.58375734 |
| 115 | MAP3K14 | 0.56853507 |
| 116 | PDPK1 | 0.56510945 |
| 117 | NUAK1 | 0.56074216 |
| 118 | DYRK1B | 0.55393360 |
| 119 | WNK1 | 0.53393065 |
| 120 | ABL1 | 0.53270891 |
| 121 | TYK2 | 0.52959838 |
| 122 | IRAK2 | 0.52787945 |
| 123 | HIPK2 | 0.52462632 |
| 124 | PRKAA1 | 0.52207583 |
| 125 | CSNK1G2 | 0.51713884 |
| 126 | CDK7 | 0.51474680 |
| 127 | MST1R | 0.49733052 |
| 128 | PIK3CG | 0.48552447 |
| 129 | JAK1 | 0.47868432 |
| 130 | WNK4 | 0.47852720 |
| 131 | BRSK2 | 0.46941710 |
| 132 | ATM | 0.46925532 |
| 133 | CHEK1 | 0.46445415 |
| 134 | PLK3 | 0.45595003 |
| 135 | TAOK2 | 0.45259856 |
| 136 | TRPM7 | 0.44283817 |
| 137 | RPS6KA4 | 0.44153146 |
| 138 | MAPK3 | 0.43674515 |
| 139 | CDK4 | 0.41902750 |
| 140 | CSNK1G3 | 0.41814706 |
| 141 | SCYL2 | 0.41750085 |
| 142 | PRKCD | 0.41524934 |
| 143 | EPHB1 | 0.41321266 |
| 144 | CDK12 | 0.40530897 |
| 145 | PKN1 | 0.40481398 |
| 146 | MARK2 | 0.39187724 |
| 147 | FYN | 0.38892176 |
| 148 | MAPK11 | 0.38382907 |
| 149 | CCNB1 | 0.37358577 |
| 150 | CDK5 | 0.36798787 |
| 151 | ADRBK2 | 0.35574942 |
| 152 | MAPK7 | 0.34558708 |
| 153 | MAP3K12 | 0.33420066 |
| 154 | STK11 | 0.32994949 |
| 155 | MAPK4 | 0.32061235 |
| 156 | BRSK1 | 0.29665698 |
| 157 | CSNK1A1L | 0.29389165 |
| 158 | MAP2K1 | 0.27540255 |
| 159 | CDK1 | 0.27177606 |
| 160 | CHUK | 0.26349852 |
| 161 | CDK2 | 0.25651839 |
| 162 | CDK6 | 0.24308830 |
| 163 | VRK1 | 0.24068692 |
| 164 | DYRK3 | 0.23930045 |
| 165 | CSNK1D | 0.23403457 |
| 166 | PIM1 | 0.22300178 |
| 167 | FRK | 0.21175224 |
| 168 | SGK2 | 0.20884588 |
| 169 | EPHA3 | 0.18372016 |
| 170 | WEE1 | 0.18134431 |
| 171 | EPHA4 | 0.17460673 |
| 172 | AKT1 | 0.16947659 |
| 173 | JAK2 | 0.16064379 |
| 174 | CAMK2A | 0.15923142 |
| 175 | MAPK10 | 0.13829142 |
| 176 | RPS6KA1 | 0.13599696 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cell cycle_Homo sapiens_hsa04110 | 3.64770069 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.63989323 |
| 3 | Basal transcription factors_Homo sapiens_hsa03022 | 3.57673446 |
| 4 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 3.39928868 |
| 5 | RNA degradation_Homo sapiens_hsa03018 | 3.05155482 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.00026410 |
| 7 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.83286546 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.81149698 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.76755191 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.74726689 |
| 11 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.62075383 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.51511537 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 2.45953620 |
| 14 | Pancreatic cancer_Homo sapiens_hsa05212 | 2.27734203 |
| 15 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.27437739 |
| 16 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.27341512 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 2.17125211 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.16807362 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.16113192 |
| 20 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 2.11589084 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 2.11019925 |
| 22 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 2.08266938 |
| 23 | Oocyte meiosis_Homo sapiens_hsa04114 | 2.08169894 |
| 24 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.99795157 |
| 25 | Homologous recombination_Homo sapiens_hsa03440 | 1.95304514 |
| 26 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.91525342 |
| 27 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.90205682 |
| 28 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.87490733 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74047473 |
| 30 | RNA transport_Homo sapiens_hsa03013 | 1.65982915 |
| 31 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.62052063 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61024055 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 1.60299091 |
| 34 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.58253304 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.58189862 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.57758765 |
| 37 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.56082497 |
| 38 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.54293809 |
| 39 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.53755785 |
| 40 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.53742157 |
| 41 | Phototransduction_Homo sapiens_hsa04744 | 1.51432763 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.48643591 |
| 43 | Long-term potentiation_Homo sapiens_hsa04720 | 1.48049727 |
| 44 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.47345887 |
| 45 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.45841543 |
| 46 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.45415879 |
| 47 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43910044 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.42854886 |
| 49 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.40513325 |
| 50 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.38759199 |
| 51 | Tuberculosis_Homo sapiens_hsa05152 | 1.36694605 |
| 52 | Colorectal cancer_Homo sapiens_hsa05210 | 1.31797421 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31560954 |
| 54 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31246799 |
| 55 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30456661 |
| 56 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.29831361 |
| 57 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.29767494 |
| 58 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.29372387 |
| 59 | Asthma_Homo sapiens_hsa05310 | 1.28151548 |
| 60 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.26371854 |
| 61 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.24190933 |
| 62 | Malaria_Homo sapiens_hsa05144 | 1.19973740 |
| 63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.19259989 |
| 64 | Endometrial cancer_Homo sapiens_hsa05213 | 1.16588587 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 1.16517072 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.16374661 |
| 67 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.15218536 |
| 68 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.13526209 |
| 69 | Measles_Homo sapiens_hsa05162 | 1.08905182 |
| 70 | Thyroid cancer_Homo sapiens_hsa05216 | 1.08733365 |
| 71 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.04723266 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.02745699 |
| 73 | Morphine addiction_Homo sapiens_hsa05032 | 1.00341138 |
| 74 | Pertussis_Homo sapiens_hsa05133 | 1.00016638 |
| 75 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.99874165 |
| 76 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.99659963 |
| 77 | Legionellosis_Homo sapiens_hsa05134 | 0.97690451 |
| 78 | Circadian entrainment_Homo sapiens_hsa04713 | 0.97267362 |
| 79 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.96960424 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.96095886 |
| 81 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.95261959 |
| 82 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.94852874 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.94302480 |
| 84 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.90859458 |
| 85 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89246197 |
| 86 | Long-term depression_Homo sapiens_hsa04730 | 0.89056416 |
| 87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.88402121 |
| 88 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.88080482 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.87573117 |
| 90 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.87500728 |
| 91 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86962396 |
| 92 | Base excision repair_Homo sapiens_hsa03410 | 0.86582511 |
| 93 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.85678266 |
| 94 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84766053 |
| 95 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.83702411 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.83485157 |
| 97 | Prostate cancer_Homo sapiens_hsa05215 | 0.83169036 |
| 98 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.82708117 |
| 99 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.82041167 |
| 100 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.82038288 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.78591339 |
| 102 | Platelet activation_Homo sapiens_hsa04611 | 0.78126957 |
| 103 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77936883 |
| 104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.77122512 |
| 105 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.75702196 |
| 106 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75647798 |
| 107 | Olfactory transduction_Homo sapiens_hsa04740 | 0.73336780 |
| 108 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.71466262 |
| 109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70512905 |
| 110 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.70116378 |
| 111 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.69615274 |
| 112 | Salivary secretion_Homo sapiens_hsa04970 | 0.68805594 |
| 113 | Taste transduction_Homo sapiens_hsa04742 | 0.68222366 |
| 114 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67831923 |
| 115 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67621405 |
| 116 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.65670695 |
| 117 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65088460 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.64936706 |
| 119 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64497419 |
| 120 | HTLV-I infection_Homo sapiens_hsa05166 | 0.64419287 |
| 121 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63925366 |
| 122 | Alcoholism_Homo sapiens_hsa05034 | 0.63448493 |
| 123 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.61998256 |
| 124 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.61366937 |
| 125 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59271398 |
| 126 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.57577274 |
| 127 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57541556 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.56576813 |
| 129 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.55492151 |
| 130 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.54513123 |
| 131 | Purine metabolism_Homo sapiens_hsa00230 | 0.54342452 |
| 132 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.51932527 |
| 133 | Other glycan degradation_Homo sapiens_hsa00511 | 0.51878295 |
| 134 | Influenza A_Homo sapiens_hsa05164 | 0.51861604 |
| 135 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.47371623 |
| 136 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.47257188 |
| 137 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.46796498 |
| 138 | Lysosome_Homo sapiens_hsa04142 | 0.46467591 |
| 139 | Hepatitis B_Homo sapiens_hsa05161 | 0.45923475 |
| 140 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.45903784 |
| 141 | Hepatitis C_Homo sapiens_hsa05160 | 0.45860896 |
| 142 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.45640583 |
| 143 | Glioma_Homo sapiens_hsa05214 | 0.44793508 |
| 144 | Shigellosis_Homo sapiens_hsa05131 | 0.44383054 |
| 145 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44278058 |
| 146 | Ribosome_Homo sapiens_hsa03010 | 0.43231403 |
| 147 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.43223116 |
| 148 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42191351 |
| 149 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.41980426 |
| 150 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41312404 |
| 151 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41088665 |
| 152 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.41077188 |
| 153 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.38796053 |
| 154 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.36935636 |
| 155 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.36893383 |
| 156 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36166184 |
| 157 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35925777 |
| 158 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.35888787 |
| 159 | Histidine metabolism_Homo sapiens_hsa00340 | 0.35270323 |
| 160 | Mismatch repair_Homo sapiens_hsa03430 | 0.34090302 |
| 161 | Lysine degradation_Homo sapiens_hsa00310 | 0.33317617 |
| 162 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.32919954 |
| 163 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.32318364 |
| 164 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.31984732 |
| 165 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.31982257 |
| 166 | Tight junction_Homo sapiens_hsa04530 | 0.31850407 |
| 167 | Melanogenesis_Homo sapiens_hsa04916 | 0.31723109 |
| 168 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31141213 |
| 169 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.27033615 |
| 170 | Amoebiasis_Homo sapiens_hsa05146 | 0.25724595 |
| 171 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.24470860 |
| 172 | DNA replication_Homo sapiens_hsa03030 | 0.22312849 |

